PLAY PODCASTS
Singapore Medical Device Registration: Navigating the HSA & Health Products Act

Singapore Medical Device Registration: Navigating the HSA & Health Products Act

Medical Device Global Market Access · Pure Global

February 20, 20262m 55s

Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

This episode provides a detailed overview of Singapore's medical device registration framework. We cover the role of the Health Sciences Authority (HSA), the foundational Health Products Act 2007 and Medical Devices Regulations 2010, the four-tiered risk classification system, and the various registration pathways available to manufacturers based on prior approvals in reference markets. - What is the primary legislation governing medical devices in Singapore? - How does the Health Sciences Authority (HSA) classify medical devices by risk? - What are the different registration pathways available for market entry? - Which countries are considered reference markets by the HSA? - Can approval from another country speed up your Singapore registration? - What is the ASEAN CSDT and why is it important for your submission? - Is a local representative required to register a medical device in Singapore? - Are all device classes required to undergo full product registration? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We leverage local expertise and advanced AI tools to streamline global market access, acting as your local representative in over 30 markets, including Singapore. Our services cover the entire product lifecycle, from regulatory strategy and technical dossier submission to post-market surveillance. Let us help you navigate complex frameworks efficiently. For more information, visit us at https://pureglobal.com, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.